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HIV-1 group M subtype B was the first HIV discovered and is the
predominant variant of AIDS virus in most countries outside of
sub-Saharan Africa. However, the circumstances of its origin and
emergence remain unresolved. Here we propose a geographic
sequence and time line for the origin of subtype B and the
emergence of pandemic HIV/AIDS out of Africa. Using HIV-1 gene
sequences recovered from archival samples from some of the
earliest known Haitian AIDS patients, we find that subtype B likely
moved from Africa to Haiti in or around 1966 (1962–1970) and then
spread there for some years before successfully dispersing else-
where. A ‘‘pandemic’’ clade, encompassing the vast majority of
non-Haitian subtype B infections in the United States and else-
where around the world, subsequently emerged after a single
migration of the virus out of Haiti in or around 1969 (1966–1972).
Haiti appears to have the oldest HIV/AIDS epidemic outside sub-
Saharan Africa and the most genetically diverse subtype B epi-
demic, which might present challenges for HIV-1 vaccine design
and testing. The emergence of the pandemic variant of subtype B
was an important turning point in the history of AIDS, but its
spread was likely driven by ecological rather than evolutionary
factors. Our results suggest that HIV-1 circulated cryptically in the
United States for12 years before the recognition of AIDS in 1981.
evolution  pandemic  phylogeny  archival  Haiti
V iral gene trees can deliver powerful insights into ecologicaland evolutionary processes (1). Population-level phyloge-
netic patterns reflect both transmission dynamics and genetic
change, which in turn can accumulate because of selection
(driven, for example, by host immunity) or drift. In this study, we
use a phylogenetic approach and HIV-1 gene sequences recov-
ered from early victims of AIDS to investigate when, where, and
how HIV-1 emerged from Africa and spread worldwide. Al-
though it accounts for fewer infections than subtype C, which
dominates the HIV-1 epidemics in southern Africa and India
and is spreading elsewhere (2), HIV-1 group M subtype B is
arguably the most widespread HIV variant. No other subtype or
circulating recombinant form predominates in as many countries
around the world (3).
Our aim here is to combine phylogenetic, molecular evolu-
tionary, historical, and epidemiological perspectives in an at-
tempt to reconstruct the history of the subtype B pandemic. Such
retrospective knowledge can clarify the past but also potentially
can be of value for rational vaccine design that takes into account
the genetic diversity of the virus (4) and for predicting the future
complexity of regional and global HIV-1 genetic diversity. This
is a function of how frequently HIV-1 strains disperse to, then
successfully colonize, new geographic ranges and host popula-
tions, a question we address here.
The idea that Haiti might have played a special role in the
unfolding of the AIDS pandemic predates the discovery of HIV.
Soon after the initial recognition of AIDS (5), evidence of a high
prevalence of the syndrome among Haitian immigrants in the
United States (6) helped fuel speculation that Haiti may have
been the source of the mysterious newly identified syndrome (7).
It has since become clear that the causative agent, HIV-1 group
M, actually originated not in Haiti but in central Africa, appar-
ently sometime around 1930 (8, 9).
Nevertheless, the possibility remains that Haiti was the step-
ping-stone for the emergence of the exceptionally widespread
subtype B lineage, and this idea has implications that extend
beyond historical interest. Some researchers have noted that
Haitian HIV-1 sequences tend to occupy basal positions on the
subtype B phylogeny, suggestive of the epidemic originating
there (9–11). Others argue vigorously that the Haitian HIV/
AIDS epidemic was seeded from the United States, perhaps
after Haiti became a popular sex tourism destination in the
mid-1970s (12–14). However, these competing hypotheses have
never been rigorously tested, despite their importance for un-
derstanding the global spread and vaccine-relevant genetic
diversity of HIV-1.
To test these hypotheses, we recovered complete HIV-1 env
and partial gag gene sequences from archival specimens collected
in 1982–1983 from five Haitian AIDS patients, all of whom had
recently immigrated to the United States and were among the
first recognized AIDS victims (6). Being independent of and
much older than the few previously published Haitian HIV-1
full-length env strains, these archival sequences offer a unique
opportunity for resolving the origin and emergence of subtype B.
They provide direct insight into Haitian HIV-1 genetic diversity
at an exceptionally early time point and an unbiased sample for
testing the a priori specified phylogenetic hypotheses addressed
here.
Results and Discussion
The Geographical Origin of Subtype B. Under the ‘‘Haiti-first’’
model, non-Haitian subtype B strains are expected to be phy-
logenetically nested within an older and hence more extensive
range of Haitian genetic variation, with Haitian lineages branch-
ing off closest to the B subtype ancestor. To test whether it is this
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or an alternative pattern that characterizes this HIV-1 subtype
[supporting information (SI) Fig. 3], we conducted a detailed
Bayesian Markov chain Monte Carlo (MCMC) phylogenetic
analysis using an alignment of the Haitian archival sequences
plus 117 previously published subtype B env sequences from a
total of 19 countries. Five African strains of subtype D (the
closest relative to subtype B) served as the outgroup.
On the env gene phylogeny, the archival sequences occupy
basal positions within subtype B (Fig. 1 and SI Fig. 4); there is
extremely strong statistical support for a Haitian origin of
subtype B, in that the probability of a U.S. or other non-Haitian
origin [i.e., the posterior probability of any non-Haitian se-
quence(s) occupying the most basal position in the B clade] is
0.001. These results indicate, with high statistical significance,
that subtype B arrived and began spreading in Haiti before it
spread elsewhere and was not originally introduced to Haiti from
the United States. In addition, the unequivocal support for the
monophyly of subtype B as a whole (P  1.0) supports the
previous suggestion of a single (epidemically successful) intro-
duction of this subtype from central Africa to Haiti (10).
Drummond et al. (15) found that relaxed-clock models are
more accurate and precise at estimating phylogenetic relation-
ships than unrooted methods. In other words, when data have
evolved in a somewhat clock-like fashion, incorporating knowl-
edge of the tempo of evolution can make topology estimation
more reliable compared with methods that ignore this informa-
tion. Therefore, we were also interested in what the relaxed-clock
results (described below) revealed with respect to where subtype
B originated (i.e., the topological relationships among subtype B
sequences, regardless of timing/branch lengths). Under the
relaxed-clock model, the posterior probability of a U.S. origin
was 0.00003, and the probability of a Haitian origin was 0.9979.
The inference that subtype B reached Haiti before spreading
to other countries does not depend on a dating analysis. One of
the advantages of a Bayesian statistical framework is that it yields
direct estimates of the probability of phylogenetic hypotheses,
and in this case there is strong evidence to reject a U.S. or other
non-Haitian origin of subtype B. This means that even if there
is some uncertainty regarding precisely when HIV-1 entered
Haiti or the United States (see below), there is little doubt about
the sequence of events; the clear-cut topological information
implies that the entry to Haiti occurred first. Moreover, our
sampling bias in favor of non-Haitian subtype B makes the
‘‘Haiti-first’’ inference conservative; the Haitian strains occupy
the basal positions within subtype B even though there were
many more opportunities for recovering non-Haitian basal
strains, if they existed.
The Dispersal of HIV-1 Out of Haiti.We next investigated how many
times the older Haitian HIV-1 epidemic has seeded detectable
secondary outbreaks elsewhere. We found evidence for only
three such events, despite the fact that our data set comprised
109 non-Haitian subtype B strains from the Caribbean, North
and South America, Europe, Africa, Asia, and Australia. One
instance is confined to Trinidad and Tobago (Fig. 1). All of the
HIV-1 sequences from this country form a distinct monophyletic
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Fig. 1. The abridged majority-rule consensus tree summarizing the results from the MrBayes analysis of complete env genes. The branch lengths represent the
mean value observed for that branch among the postburnin sampled trees. Posterior probabilities are indicated for each node. As expected under a ‘‘Haiti-first’’
model, the non-Haitian subtype B strains are phylogenetically nested within an older and more diverse range of Haitian viral variants. The 11 sequences of the
Trinidad and Tobago clade and the 96 sequences of the pandemic clade are schematically represented by the blue and yellow triangles, respectively. Haitian or
Haitian-linked sequences are shown in green, with the archival sequences labeled in larger bold text. The unabridged tree is available as SI Fig. 4.
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grouping with the strongest possible support (posterior proba-
bility of 1.0). Previous studies have asserted homosexual/bisexual
contact with North American foreigners in the late 1970s or early
1980s as the alleged route of introduction (16, 17). Our results
indicate this was not the case; the Trinidad and Tobago clade is
unequivocally nested among Haitian strains, not North Ameri-
can ones, clear evidence that the predominantly heterosexual
epidemic in this country can be explained by a single introduc-
tion linked to Haiti.
The next, and most important, secondary epidemic accounts
for all but three of the remaining non-Haitian strains, encom-
passing 96 sequences representing every other country in our
data set (Fig. 1). This ‘‘pandemic’’ clade forms another unequiv-
ocally monophyletic cluster (P  1.0) nested within the basal
Haitian strains. As for the Trinidad and Tobago clade, the most
parsimonious explanation for this pattern is that all these
subtype B infections from across the world emanated from a
single founder event linked to Haiti. This most likely occurred
when the ancestral pandemic clade virus crossed from the
Haitian community in the United States to the non-Haitian
population there.
The only other Haiti-linked outbreak we detected is compar-
atively insignificant, here comprising a single Brazilian sequence
(BR020) and one American one (US4). Additional rare chains
of transmission may have emerged from Haiti but remained
undetectable in this study. Likewise, pandemic clade viruses may
have reentered Haiti but were undetectable. Regardless, it is
evident from this large international sample that the subtype B
epidemics in most aff licted countries and the bulk of subtype B
infections worldwide are caused by viruses belonging only to the
pandemic clade.
Three additional nominally non-Haitian strains are notewor-
thy for falling among the basal Haitian lineages rather than
within the three non-Haitian clades (Fig. 1). Each one provides
further support for the notion that strains linked to Haiti occupy
the deepest branches within subtype B. RF was sampled in 1983
from a Haitian immigrant to the United States. Like our five
newly sequenced strains, it represents a Haitian strain that
entered the United States via an immigrant host (10). WMJ2 was
sampled in 1985 from a perinatally infected infant born to an
HIV-positive Haitian immigrant mother (18). KR5086 was
recovered in 1995 from a South Korean sailor infected in the
Dominican Republic (19), a country directly linked to Haiti in
terms of both geography and HIV-1 epidemiology (20). These
cases, plus the additional ones considered in our study, show that
the virus moved out of Haiti on many separate occasions but did
so mostly as dead-end infections that evidently failed to ignite
successful epidemics. A key question for future research will be
to determine why Haiti-to-U.S. epidemic outbreaks have appar-
ently become established so rarely since the initial introduction
in or around 1969, despite presumably frequent movement of the
virus because of rising HIV-1 prevalence, continued migration,
and the once-thriving sex tourism industry linking Haiti and the
United States.
Several additional analyses corroborated these findings. First,
we reanalyzed our env gene data by replacing the African
subtype D outgroup sequences with a variety of alternatives from
different subtypes and geographical regions. This had no impact
on the basal position of the Haitian strains within subtype B (SI
Fig. 5a); their ancestral position cannot be dismissed as an
artifact of convergent evolution with African subtype D se-
quences. Second, the gag sequences also unambiguously place
the Haitian sequences in the most ancestral positions within
subtype B (P  0.9930) (SI Fig. 5b). We also inspected the
nucleotide substitutions that mapped specifically onto the
branch leading to the pandemic clade. For env, all eight such
changes were silent at the amino acid level. For gag, only one of
the six changes on the relevant branch indicated a change in
amino acid between the Haitian strains and the pandemic clade
strains. The paucity of amino acid substitutions along this
clade-defining branch suggests that the ancestor of the pandemic
clade probably possessed no selective advantage over other
Haitian strains; its remarkable epidemic success may simply
reflect ecological factors rather than evolutionary ones (chance
colonization of a new population, as opposed to competitively
superior transmission fitness). However, analysis of complete
genomes would be necessary to definitively rule out selection.
The Timing of the Emergence of Subtype B. We used a second
Bayesian MCMC method that simultaneously estimates phylo-
genetic relationships and times of most recent common ancestors
(15) to perform a supplementary phylogenetic analysis on a
reduced data set. This method uses a ‘‘relaxed molecular clock’’
model, so-called because it relaxes the need to assume a constant
rate of molecular evolution across the tree to obtain date
estimates from gene sequences. We estimated the time of the
most recent common ancestor (TMRCA) of subtype B at 1966
(1962–1970) (Fig. 2), a date that suggests its arrival in Haiti may
have occurred with the return of one of the many Haitian
professionals who worked in the newly independent Congo in the
1960s (21).
The TMRCA of the U.S. epidemic is estimated to be 1969
(1966–1972) (Fig. 2), suggesting that HIV-1 was circulating
cryptically in the United States for 12 years before the initial
recognition of AIDS in 1981. The evidence of a single origin of
the pandemic variant of subtype B allowed us to date the
beginning of the actual U.S. HIV-1 epidemic, rather than the
ancestor of multiple viruses introduced from Haiti; if multiple
introductions fromHaiti had occurred, the ‘‘U.S. MRCA’’ would
actually correspond to a Haitian virus that predated the initial
entry of HIV-1 to the United States (11). Serological evidence
of an 5% prevalence of HIV-1 by 1978 in men who have sex
with men (MSM) populations in both San Francisco (22) and
New York City (23) suggests that several thousand individuals in
the United States would already have been infected by then.
Even assuming the fastest-documented growth rates for HIV-1
(24), this implies that the virus had been spreading in the MSM
population for several years before this point, consistent with our
19
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19
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[19
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USA/
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& Tobago
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Fig. 2. The consensus tree of the relaxed molecular clock analysis, with the
Haitian archival sequences bulleted. The tips of the tree correspond to year of
sampling, and the branch lengths reflect the mean of the posterior probability
density. The posterior probability density for the TMRCA for subtype B in Haiti
is depicted in dark green, and the 95% highest probability density (HPD) is
shown by the horizontal bar and light-green shading. The TMRCA means and
95% HPDs for the other key nodes were as follows: subtype B/D ancestor 
1954 (1946–1961); subtype D ancestor  1966 (1961–1971); Trinidad and
Tobago subtype B ancestor  1973 (1970–1976); and U.S./Canada subtype B
ancestor1969 (1966–1972). This analysis resolves the position of the archival
sequence H6 as basal to the pandemic clade. Under the relaxed molecular
clock, Pnon-Haitian-origin 0.00003, Psimultaneous-origin 0.0021, and PHaitian-origin
0.9979.
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findings here. The virus may well have been spreading slowly for
an extensive period, perhaps in the heterosexual population,
before entering the highest-risk MSM subpopulation, where it
spread explosively enough to finally be noticed. We contend that
the phylogenetic estimate, with appropriate confidence inter-
vals, provides more reliable information on the date of the origin
of the U.S. epidemic than the available epidemiological data,
which cannot resolve this question.
Nevertheless, although our relaxed-clock methods should be
reasonably robust to rate variation among lineages and uncer-
tainty in phylogenetic inference, some caution is always war-
ranted when such inferences are made. For example, the rela-
tively sparse sampling of both Haitian and Trinidadian
sequences means it is conceivable that more intensive future
sampling could recover deeper-branching lineages and push
back these TMRCA estimates slightly. This is unlikely to apply
to the U.S. TMRCA, on the other hand, because of the already
dense sampling of this HIV-1 population. If obtainable, addi-
tional archival sequences should help clarify the early spread of
subtype B with greater precision.
The three-decade gap between the estimated timing of the
HIV-1 M group ancestor (9) and the earliest evidence of
HIV/AIDS in Africa (25, 26) seems unexceptional in compari-
son to the U.S. cryptic period, especially because a good deal of
tuberculosis-caused mortality in Africa must have gone unrec-
ognized as AIDS-related, then as now. Taken together with our
dating analysis, including the subtype B/D ancestor dated to 1954
(1946–1961) (Fig. 2), the extensive cryptic period in the United
States, therefore, provides compelling corroboration of an early
20th century M group ancestor (9).
Conclusion
Our findings imply that Haiti has the oldest-known HIV/AIDS
epidemic outside of sub-Saharan Africa, which helps explain the
high prevalence of AIDS and HIV-1 among Haitians in the early
1980s. Because of its 40-year history, the HIV-1 epidemic in
Haiti exhibits a greater range of viral genetic diversity than the
rest of the world’s subtype B strains combined, much as the
HIV-1 epidemic in the Democratic Republic of the Congo does
for group M as a whole (27). This raises the possibility that
subtype B strains in Haiti or elsewhere might exhibit distinct or
more diverse antigenic properties compared with pandemic
clade viruses. Vaccines derived from consensus or other central
sequences should perhaps be based on extensive sampling of
Haitian HIV-1 if they are intended to cover bothHaitian subtype
B strains as well as the pandemic clade.
Although it has long been clear that population bottlenecks
and founder effects are a feature of the unfolding HIV/AIDS
pandemic, the series of bottlenecks that punctuated the global
emergence of subtype B is remarkable. The lack of evidence for
selection associated with the spread of the pandemic clade of
subtype B, moreover, points to the importance of chance events
and ecological interactions in driving what was perhaps the most
explosive worldwide dispersal of HIV-1.
Our phylogenetic estimates of timing anchor previous epide-
miological observations that, on their own, cannot reliably date
the origin of regional epidemics. Taken together, these sources
of information suggest that HIV-1 was circulating in one of the
most medically sophisticated settings in the world for more than
a decade before AIDS was recognized.
Methods
The Archival Samples. Peripheral blood mononuclear cell (PBMC)
samples were collected in 1982 and 1983 at Jackson Memorial
Hospital in Miami, FL, during one of the first investigations
establishing that Haitians in Haiti and elsewhere were at risk for
AIDS (6). One of the six PBMC samples obtained for this study
failed to yield any amplifiable HIV-1 PCR products. As de-
scribed in Pitchenik et al. (6), all of the patients were Haitian
immigrants who had entered the United States after 1975 and
progressed to AIDS by 1981 and hence were presumably infected
with HIV-1 before entering the United States. The position of
these sequences on the subtype B phylogeny (distinct from and
basal to the dominant U.S. variant of subtype B) is consistent
with this sequence of events.
Amplification and Sequencing of Archival HIV-1 DNA. DNA was
extracted from 10 l of peripheral blood mononuclear cells by
using QIAamp DNA micro kits (Qiagen, Valencia, CA), follow-
ing the manufacturer’s instructions for extractions from blood.
After extraction, DNA was eluted into 100 l of elution buffer
AE and stored frozen at20°C until required for DNA analyses.
DNA was PCR-amplified from the extracts by using a nested
PCR approach (28). First-round PCRs were undertaken in 25 l
of final volume reactions, using 0.1 l of Platinum Taq HiFi
enzyme (Invitrogen, Carlsbad, CA)/0.1 l of 25 mM dNTP
mix/2.5 mM (final concentration) MgSO4/10 PCR buffer/1–5
l of DNA extract. Second-round amplifications were per-
formed on 1 l of the first-round PCR product by using the same
reagent concentrations. Enzyme activation, dissociation, and
extension temperatures followed the manufacturer’s guidelines,
with an extension time of 3 min. Annealing temperatures varied
by extract in response to initial amplification success rates.
After amplification, the PCR products were visualized on
0.8% agarose gels stained with ethidium bromide and then
purified by using QIAquick spin columns (Qiagen). Purified
products were sequenced by using several overlapping primer
pairs (28) by the University of Arizona Genomic Analysis and
Technology Core Facility with ABI Big Dye 3.1 chemistry
(Applied Biosystems, Foster City, CA) on Applied Biosystem
3730xl DNA Analyzers. Each sample was extracted, PCR-
amplified, and sequenced twice to ensure that the sequences
generated were not modified through low template copy num-
ber. We recovered five full-length env sequences and five partial
(0.7- to 1.2-kb) gag sequences.
Sequence Alignments. We used the Los Alamos National Labo-
ratory HIV sequence database (29) to download all full-length
published env and gag gene sequences of subtypes B and D. We
then subjected the resulting sequence set to strict quality control
measures to remove (i) incomplete sequences; (ii) sequences not
published in a peer-reviewed journal; (iii) multiple sequences
from the same patient; (iv) sequences suspected a priori of
possibly anomalous evolutionary patterns (from long-term non-
progressors with nef deletions, laboratory workers infected
accidentally, sequences exhibiting evidence of hypermutation,
etc.); (v) sequences with midpeptide stop codons, frame-shift
mutations, or nonnucleotide characters; or (vi) sequences for
which there was any uncertainty regarding which subtype they
belonged to. To search for such sequences, which might include
unidentified intersubtype recombinants, we screened all se-
quences using the REGA HIV-1 Subtyping Tool (30) and then
removed any sequence with bootstrapping support 100% or
bootscanning support 1.0 for clustering with subtype B or D.
To ensure that no very-early-diverging subtype B strains were
removed by this procedure, we inferred additional phylogenies
that included the ‘‘cleaned’’ sequences (data not shown). For env,
the only such strains that were positioned basal to the pandemic
clade were from Trinidad and Tobago, and these clustered with
the other sequences from the Trinidad and Tobago clade.
Similarly, for gag, the only nonpandemic clade sequences that
were removed (US4 and RF) were ones that had already been
identified as basal in the env analysis; all other sequences with
bootstrap or bootscan support 100% or 1.0 were from the
pandemic clade. Unlike intersubtype recombinants, the possible
nonexclusion of intrasubtype recombinants is not expected to
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affect inferences regarding the geographical origin and emer-
gence of subtype B because intrasubtype recombination cannot
plausibly lead to strains from one locality systematically falling
basal to all of the others. Moreover, although unidentified
intrasubtype recombination might increase the variance of dat-
ing estimates, it is unlikely to systematically bias these dates in
one direction or the other in an exponentially growing popula-
tion (31).
The resulting data sets were codon-aligned and then adjusted
by eye in Squint Ver. 1.0 (M. Goode, University of Auckland,
Auckland, New Zealand), and regions of ambiguous alignment
were removed. We constructed three additional env alignments
replacing the D subtype outgroup with a subtype C sequence
from India, a subtype A sequence fromKenya, or a CRF01 (A/E)
sequence from Thailand. All previously published sequences
(see the taxon labels in SI Figs. 4 and 5b) are available from the
Los Alamos National Laboratory HIV sequence database. All
alignments are available from the authors upon request.
The Bayesian MCMC Phylogenetic Analysis and Estimation of the
Probability of a Haitian or non-Haitian Origin of Subtype B.We used
MrBayes, Ver. 3.1 (32), to perform two independent runs of 20
million steps (for env). Examination of the MCMC samples with
Tracer, Ver. 1.3 [A. Rambaut (University of Edinburgh) and
A. J. Drummond (University of Auckland, Auckland, New
Zealand); http://beast.bio.ed.ac.uk], indicated adequate mixing
of the Markov chain. We discarded the first 2 million steps from
each run as burn-in and combined the resulting MCMC samples
(n 36,002) for subsequent estimation of posteriors. Fewer steps
(5 million) were required for convergence and adequate mixing
in the gag analyses.
We used tree filtering in PAUP, Ver. 4.0b10 (33), to calculate the
posterior probabilities of a Haitian, non-Haitian, or effectively
simultaneous Haitian/non-Haitian origin of subtype B. Briefly, we
removed from the posterior sample any tree with a Haitian se-
quence(s) in the most basal position. Only 4 of 36,002 env trees had
a non-Haitian basal sequence (Pnon-Haitian-origin  0.00011), and 24
others placed theHaitian andnon-Haitian sequences in reciprocally
monophyletic clades (Psimultaneous-origin 0.00066), which left 35,974
with a Haitian sequence or group of sequences, in the most-
ancestral position(s) within subtype B (PHaitian-origin  0.9992). A
similar approach was followed for the estimation of the probability
of a Haitian or non-Haitian origin of subtype B for the gag and the
relaxed-clock analyses.
For both the env and gag data sets, we used a parsimony
approach as implemented in MacClade, Ver. 4.08 (34), to
identify the nucleotide substitutions that mapped onto the
branch leading to the pandemic clade of subtype B. We then
determined whether these changes were synonymous or non-
synonymous.
The Relaxed Molecular Clock Analysis. To infer the timescale of
HIV-1 group M subtype B evolution, we used a Bayesian
molecular clock method (15), as implemented in BEAST (http://
beast.bio.ed.ac.uk), under an uncorrelated log-normal relaxed
molecular clock model with a Bayesian Skyline coalescent tree
prior. For this analysis to run in a reasonable time, we considered
only subtype B sequences from Haiti, Trinidad and Tobago, and
the United States (plus one from Canada), and we removed
some pandemic clade sequences from overrepresented years and
localities. The maximum a posteriori tree from the MrBayes
analysis (available upon request) revealed that the sequences
were scattered across the entire pandemic clade, consistent with
a U.S. entry of the founding virus. We ran 10 independent
MCMC analyses, with each run consisting of 100 million steps,
and then discarded the first 5 million steps from each run as
burn-in and combined the resulting postburn-in MCMC samples
for subsequent estimation of posteriors.
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